Immunotherapy is an important part of treatment
to fight some types of cancer by boosting the patient’s immune system. This
therapy can be used in different ways, including stimulating the body’s immune
system to attack cancer cells and providing components of the immune system
(man-made immune system proteins called antibodies).
 |
| www.gapsos.com |
After a long time, researchers found that the
immune system could affect certain cancers. In the late 1800s, William Coley
first recognized that in cancer patients, getting an infection after surgery.
He began treatment of cancer patients with certain kinds of bacteria (Coley
toxin).
The main types of immunotherapy used in the
treatment of cancer include monoclonal antibodies, cancer vaccine and
non-specific immunotherapy. Monoclonal antibodies boost the immune system and
can be designed to attack a very specific protein that helps in the growth of
cancer cell. These antibodies stop cancer cells from growing by binding to
those proteins. Due to this reason, these types of treatment are also called
targeted therapy. Advance forms of monoclonal antibodies are less likely to
cause an immune reaction.
Vaccines are now often given along with adjuvants
that help boost the immune response.
Researchers are still studying to find the best way to give vaccines for
better response when used alone.
Non-specific immune therapies do not target
specific part of cancer cells. Cytokines are those chemicals which are made by
some immune system cells. They are controlling the growth and activity of other
immune system cells. Interleukins (group of cytokines) helps in growth of
immune system cells. Interleukin-2 (man-made version) is approved to treat
metastatic cancer and kidney cancer. Some other drugs in non-specific way that
are not naturally found in the body, but boost the immune system are known as immune
modulating drugs.
GAP has the advance technology and the expert
team for immunotherapy. GAP has capability for new development of the
immunotherapeutic cancer agents. Our expert team easily understand the
molecular basis of the interactions between targeted anti-cancer agents and the
immune system and also helps the patients in planning their treatment strategy
throughout their different types of solid tumor cancers like breast and
prostate, melanoma and colorectal.
For more information kindly visit us at www.gapsos.com
No comments:
Post a Comment